Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term phase III study of HP-3000 (ropinirole patch) in Parkinson's disease
jRCT2080222696Phase 3
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ropinirole in Parkinson's disease (PD), sponsored by Hisamitsu Pharmaceutical Co., Inc.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080222696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222696.